BackIdexx Laboratories Overview

Idexx Laboratories Current Cash

Idexx Laboratories's current cash is $200M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$196.93M
19.65% YoYΔ $32.34M vs prior year quarter

Peer average

Loading

Idexx Laboratories Current Cash History

Loading

Idexx Laboratories vs. peers: Current Cash Comparison

Loading

Idexx Laboratories Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Idexx Laboratories (IDXX) FAQ

As of the most recent data (June 2026), IDXX shows a current cash of $200M. That compares with $160M in the prior-year period — up 19.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IDXX's current cash is now $200M (was $160M) — a 19.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Idexx Laboratories is outperforming or lagging.

Tracking IDXX's current cash over time shows whether Idexx Laboratories is scaling, shrinking, or reshaping that part of the business. The current reading is $200M That compares with $160M in the prior-year period — up 19.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Idexx Laboratories's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $200M) with ownership activity and broader fundamentals.

Idexx Laboratories's current cash is $200M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.